Renzenbrink & Partner advises funds advised by IK Investment Partners (Mid Cap VIII) on the acquisition of the Ondal Group from Capvis. The closing of the transaction is still subject to antitrust clearance. The parties have agreed not to disclose the purchase price. <\/p>\n\n
Ondal was founded in 1945 and has developed into the world’s leading supplier of medical stretcher systems up to 1,000 kg. With its innovative and broad product portfolio, which is used in operating theaters, intensive care units and diagnostic and imaging rooms, Ondal sets the global quality standard for medical stretcher systems in terms of reliability, functionality and user-friendliness. Headquartered in H\u00fcnfeld, Ondal has three production sites in Germany, the USA and China and employs over 500 people. <\/p>\n\n
Capvis acquired Ondal in 2012. Since then, Ondal’s product platform has been successfully expanded through substantial investments in innovation and underpinned by numerous new patents. <\/p>\n\n
The Renzenbrink & Partner team advised IK Investment Partners on all corporate and tax aspects of the transaction. The team consisted of Dr. Ulf Renzenbrink<\/a> (Private Equity, lead), Marc H. Kotyrba<\/a> (Tax), Dr. Andreas Stoll<\/a> (Private Equity) and Dr. Gunnar L. Schm\u00fcser (Finance) as well as the associates Dr. Niels Maier<\/a>, Martin Aisenbrey and Antonia Neumerkel<\/a>. <\/p>\n","protected":false},"featured_media":1370,"template":"","class_list":["post-1427","deals","type-deals","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"\n